Holen Sie sich die Stockscreener-App
6.23
2.13%
0.13
Schlusskurs vom Vortag:
$6.10
Offen:
$6.1
24-Stunden-Volumen:
3.42M
Relative Volume:
1.13
Marktkapitalisierung:
$760.08M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-17.11
EPS:
-0.3641
Netto-Cashflow:
$-24.91M
1W Leistung:
+1.30%
1M Leistung:
+11.65%
6M Leistung:
+74.02%
1J Leistung:
+63.09%
1-Tages-Spanne:
$5.99
$6.24
1-Wochen-Bereich:
$5.99
$6.735
52-Wochen-Spanne:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Firmenname
Aquestive Therapeutics Inc
Sektor
Telefon
908-941-1900
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Vergleichen Sie AQST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
6.23 | 744.22M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-28 | Eingeleitet | Raymond James | Outperform |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-04-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-03 | Eingeleitet | Lake Street | Buy |
| 2018-08-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-08-20 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Is Aquestive Therapeutics Stock Built to Withstand a Pullback? - Trefis
Pale Fire Capital SE Acquires 340,767 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Looking at the Narrative for Aquestive Therapeutics After New Anaphylm Patents and FDA Momentum - Yahoo Finance
Aquestive Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Published on: 2025-12-08 02:09:31 - BỘ NỘI VỤ
Diametric Capital LP Acquires Shares of 165,373 Aquestive Therapeutics, Inc. $AQST - MarketBeat
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
What analyst consensus says on Aquestive Therapeutics Inc. stockJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
VP Cioffi Surrenders 2,083 Of Aquestive Therapeutics Inc [AQST] - TradingView
Sio Capital Management LLC Buys 555,860 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Published on: 2025-12-03 04:52:42 - Newser
Aquestive Therapeutics (AQST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Everstar Asset Management LLC Raises Holdings in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Quarterly Trades: Why Aquestive Therapeutics Inc. stock could see breakout soon - BỘ NỘI VỤ
Returns Recap: Why Aquestive Therapeutics Inc. stock could see breakout soonPrice Action & Capital Efficiency Focused Ideas - moha.gov.vn
What technical charts say about Aquestive Therapeutics Inc. stockWeekly Investment Summary & Weekly Stock Breakout Alerts - BỘ NỘI VỤ
Aquestive Therapeutics (NASDAQ:AQST) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Aquestive’s Anaphylm Shows Positive Results in First Study in Kids - Allergic Living
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
How Recent Regulatory Wins Are Shaping the Narrative for Aquestive Therapeutics - Yahoo Finance
Aquestive Therapeutics Shares Rise After $75 Million Funding Deal - MSN
Why Aquestive Therapeutics Inc. stock is favored by top institutionsTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
How to monitor Aquestive Therapeutics Inc. with trend dashboardsEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Can Aquestive Therapeutics Inc. stock sustain revenue growthPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail tradersMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51 - MSN
Aquestive Therapeutics Inc. stock momentum explainedMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.Swing Trade & Real-Time Market Sentiment Reports - newser.com
Aquestive Therapeutics (NASDAQ:AQST) Trading Up 6.5%Here's Why - MarketBeat
Officer Kraus Files To Sell 53,100 Of Aquestive Therapeutics Inc [AQST] - TradingView
Will Aquestive Therapeutics Inc. bounce back from current supportLayoff News & AI Based Buy and Sell Signals - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Predicting Aquestive Therapeutics Inc. trend using moving averagesJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges - MSN
Aquestive Therapeutics (NASDAQ:AQST) Updates Amid Dow Jones Industrial Average - Kalkine Media
Why Aquestive Therapeutics Inc. stock is favored by pension fundsPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors - simplywall.st
Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.87%
4.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):